Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Lupus Science & Medicine|March 18, 2026
Measurement of haemolytic anaemia in a novel treatment response measure for SLE clinical trialsKathryn Connelly, Eric Morand, Rachel Koelmeyer, et al.Journal of Clinical Medicine|December 23, 2023
COVID-19 Vaccination-Related Delayed Adverse Events among Patients with Systemic Lupus ErythematosusMrinalini Dey, Bohdana Doskaliuk, Julius Lindblom, et al.International Journal of Rheumatic Diseases|May 9, 2024
Listening to patients, for the patients: The COVAD Study-Vision, organizational structure, and challengesMrudula Joshi, Naitica Darooka, Sreoshy Saha, et al.Rheumatology International|April 12, 2024
Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD StudiesEsha Kadam, Mahnoor Javaid, Parikshit Sen, et al.Rheumatology Advances in Practice|December 7, 2023
Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scopeMd Yuzaiful Md Yusof, Eve M D Smith, Sammy Ainsworth, et al.Rheumatology (Oxford, England)|June 23, 2026
The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosusMd Yuzaiful Md Yusof, Eve M D Smith, Hanna Lythgoe, et al.Rheumatology International|October 22, 2022
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) surveyLeonardo Santos Hoff, Naveen Ravichandran, Samuel Katsuyuki Shinjo, et al.Annals of the Rheumatic Diseases|October 12, 2023
EULAR recommendations for the management of systemic lupus erythematosus: 2023 updateAntonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, et al.Rheumatology (Oxford, England)|March 24, 2023
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveysKshitij Jagtap, R Naveen, Jessica Day, et al.Rheumatology (Oxford, England)|March 2, 2024
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD studyLeonardo Santos Hoff, Naveen Ravichandran, Parikshit Sen, et al.Pageof 7